Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.
| Last: | $1.17 |
|---|---|
| Change Percent: | -4.88% |
| Open: | $1.22 |
| Close: | $1.23 |
| High: | $1.24 |
| Low: | $1.15 |
| Volume: | 439,454 |
| Last Trade Date Time: | 03/11/2026 12:45:10 pm |
| Market Cap: | $4,543,696 |
|---|---|
| Float: | 4,349,802 |
| Insiders Ownership: | N/A |
| Institutions: | 3 |
| Short Percent: | N/A |
| Industry: | Medical Diagnostics & Screening |
| Sector: | Healthcare |
| Website: | https://www.bioaffinitytech.com |
| Country: | US |
| City: | San Antonio |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about bioAffinity Technologies Inc. (NASDAQ: BIAF).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
